The brief
- Sells clonal DNA up to 50 kb, which it calls the longest sequence-perfect synthetic DNA on the market (Oct 2025).
- Direct enzymatic synthesis of fragments up to 900 bases; chemically made constructs rarely exceed 10 kb.
- Raised $68M Series A (2022) and $54.4M Series B (2025); manufactures only in the US.
